Loading…
Lobbying Spend
—
Filings
83
Firms Hired
2
Active Period
2007–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Defense Authorization Act for Fiscal Year 2025
2024 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Client expense: — · Firm income: $20,000
Matched citations: S. 4638
National Defense Authorization Act for Fiscal Year 2025
2024 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Client expense: — · Firm income: $20,000
Matched citations: S. 4638
National Defense Authorization Act for Fiscal Year 2025
2024 · third_quarter · Firm: GOVERNMENT COUNSEL, LLC
S. 4638- National Defense Authorization Act for Fiscal Year 2025 (NDAA) relating to generic drug procurement.
Client expense: — · Firm income: $20,000
Matched citations: S. 4638
Expanding Access to Low-Cost Generics Act of 2023
2023 · second_quarter · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to the structure of the Hatch-Waxman Act's 180-day exclusivity provision (S.1114). Monitor domestic pharmaceutical production legislation.
Client expense: — · Firm income: $50,000
Matched citations: S.1114
Block Grant Assistance Act of 2023
2023 · second_quarter · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to the structure of the Hatch-Waxman Act's 180-day exclusivity provision (S.1114). Monitor domestic pharmaceutical production legislation.
Client expense: — · Firm income: $50,000
Matched citations: s 180
Block Grant Assistance Act of 2023
2023 · first_quarter · Firm: GOVERNMENT COUNSEL, LLC
Issues relating to the structure of the Hatch-Waxman Act's 180-day exclusivity provision.
Client expense: — · Firm income: $50,000
Matched citations: s 180
Public Law 117-328-Consolidated Appropriations Act, 2023, relating to 180-day exclusivity reform in S. 4348 (FDASLA Act of 2022).
Client expense: — · Firm income: $50,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: GOVERNMENT COUNSEL, LLC
Monitor issues relating to negotiating Medicare prescription drug prices in the Inflation Reduction Act (H.R. 5376).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act relating to 180-day exclusivity reform.
Client expense: — · Firm income: $50,000
Matched citations: S. 4348
Expanding Access to Low-Cost Generics Act of 2021
2022 · second_quarter · Firm: GOVERNMENT COUNSEL, LLC
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act relating to 180-day exclusivity reform. S.2910 - Expanding Access to Low-Cost Generics Act of 2021.
Client expense: — · Firm income: $50,000
Matched citations: S.2910
S. 4348-Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act relating to 180-day exclusivity reform. S.2910 - Expanding Access to Low-Cost Generics Act of 2021.
Client expense: — · Firm income: $50,000
Matched citations: S. 4348
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 2740
Expanding Access to Low-Cost Generics Act of 2021
2022 · first_quarter · Firm: GOVERNMENT COUNSEL, LLC
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act.
Client expense: — · Firm income: $50,000
Matched citations: S.2910
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act; H.R. 5376-Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5376
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act; H.R. 5376-Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 2740
Expanding Access to Low-Cost Generics Act of 2021
2021 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act; H.R. 5376-Build Back Better Act.
Client expense: — · Firm income: $50,000
Matched citations: S.2910
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 2740
Expanding Access to Low-Cost Generics Act of 2021
2021 · third_quarter · Firm: GOVERNMENT COUNSEL, LLC
S.2910 - Expanding Access to Low-Cost Generics Act of 2021; S. 2740-Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act.
Client expense: — · Firm income: $50,000
Matched citations: S.2910
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 133-Consolidated Appropriations Act of 2021 relating to H.R. 938-The Blocking Act and S. 1895-Lower Health Care Costs Act (Section 205).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 133
H.R. 133-Consolidated Appropriations Act of 2021 relating to H.R. 938-The Blocking Act and S. 1895-Lower Health Care Costs Act (Section 205).
Client expense: — · Firm income: $50,000
Matched citations: H.R. 938
Lower Health Care Costs Act
2020 · fourth_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 133-Consolidated Appropriations Act of 2021 relating to H.R. 938-The Blocking Act and S. 1895-Lower Health Care Costs Act (Section 205).
Client expense: — · Firm income: $50,000
Matched citations: S. 1895
Strengthening Health Care and Lowering Prescription Drug Costs Act
2020 · third_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S.1895-Lower Health Care Costs Act (Section 205); Issues relating to the global pharmaceutical supply chain.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 987
Lower Health Care Costs Act
2020 · third_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S.1895-Lower Health Care Costs Act (Section 205); Issues relating to the global pharmaceutical supply chain.
Client expense: — · Firm income: $50,000
Matched citations: S.1895
Strengthening Health Care and Lowering Prescription Drug Costs Act
2020 · second_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S.1895-Lower Health Care Costs Act (Section 205); Issues relating to the global pharmaceutical supply chain.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 987
Lower Health Care Costs Act
2020 · second_quarter · Firm: GOVERNMENT COUNSEL, LLC
H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S.1895-Lower Health Care Costs Act (Section 205); Issues relating to the global pharmaceutical supply chain.
Client expense: — · Firm income: $50,000
Matched citations: S.1895
Source: Senate LDA